Published in

American Chemical Society, Organic Process Research and Development, 2(20), p. 551-557, 2016

DOI: 10.1021/acs.oprd.5b00349

Links

Tools

Export citation

Search in Google Scholar

Recyclable NHC Catalyst for the Development of a Generalized Approach to Continuous Buchwald–Hartwig Reaction and Workup

This paper is available in a repository.
This paper is available in a repository.

Full text: Download

Green circle
Preprint: archiving allowed
  • Must obtain written permission from Editor
  • Must not violate ACS ethical Guidelines
Orange circle
Postprint: archiving restricted
  • Must obtain written permission from Editor
  • Must not violate ACS ethical Guidelines
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

A generalized approach to the optimization and implementation of Buchwald Hartwig reactions in flow is reported, through the combination of three key factors: a highly active palladium catalyst, a universal approach for continuous workup and purification, and a methodology for catalyst recycling and reuse. The palladium N-heterocyclic carbene (NHC) precatalyst [Pd(IPr*)(cin)Cl] 4 (IPr* = 1,3-bis(2,6-bis(diphenylmethyl)-4-methylphenyl)imidazol-2-ylidene; cin = eta(3)-cinnamyl) is an excellent choice for continuous Buchwald Hartwig reactions, due to its inherent high activity and stability. In preparation for running this reaction in flow (published concurrently), a detailed study has been carried out into its water stability, ultimately allowing the recycling of the catalyst in the organic phase up to three times in batch mode. A "right-first-time" workup methodology has also been developed, resulting in a universal protocol that allows the selective extraction of the Buchwald-Hartwig product into the aqueous stream as a salt, while retaining the aryl bromide starting material in the organic stream with the catalyst, thus negating the requirement for further purification. It is therefore envisaged that this approach will be particularly amenable to exploitation in the pharmaceutical industry. An optimized, scalable synthesis of [Pd(IPr*)(cin)Cl] is also reported on the multihundred gram scale.